506 related articles for article (PubMed ID: 9469424)
1. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
[TBL] [Abstract][Full Text] [Related]
2. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
[TBL] [Abstract][Full Text] [Related]
4. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.
Somasundaram C; Sundarapandiyan K; Keler T; Deo YM; Graziano RF
Hum Antibodies; 1999; 9(1):47-54. PubMed ID: 10331185
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.
Keler T; Wallace PK; Vitale LA; Russoniello C; Sundarapandiyan K; Graziano RF; Deo YM
J Immunol; 2000 Jun; 164(11):5746-52. PubMed ID: 10820252
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG
Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
Connor RI; Shen L; Fanger MW
J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
[TBL] [Abstract][Full Text] [Related]
8. Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation.
Patry C; Herbelin A; Lehuen A; Bach JF; Monteiro RC
Immunology; 1995 Sep; 86(1):1-5. PubMed ID: 7590867
[TBL] [Abstract][Full Text] [Related]
9. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
10. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii.
Erbe DV; Pfefferkorn ER; Fanger MW
J Immunol; 1991 May; 146(9):3145-51. PubMed ID: 1826707
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
Russoniello C; Somasundaram C; Schlom J; Deo YM; Keler T
Clin Cancer Res; 1998 Sep; 4(9):2237-43. PubMed ID: 9748144
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
van der Steen L; Tuk CW; Bakema JE; Kooij G; Reijerkerk A; Vidarsson G; Bouma G; Kraal G; de Vries HE; Beelen RH; van Egmond M
Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface.
Graziano RF; Fanger MW
J Immunol; 1987 Feb; 138(3):945-50. PubMed ID: 2949010
[TBL] [Abstract][Full Text] [Related]
14. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
15. Induction of intracellular Ca2+ mobilization and cytotoxicity by hybrid mouse monoclonal antibodies. Fc gamma RII regulation of Fc gamma RI-triggered functions or signaling?
Koolwijk P; Van de Winkel JG; Pfefferkorn LC; Jacobs CW; Otten I; Spierenburg GT; Bast BJ
J Immunol; 1991 Jul; 147(2):595-602. PubMed ID: 1830069
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Chen J; Zhou JH; Ball ED
Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
[TBL] [Abstract][Full Text] [Related]
17. Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy.
Bakema JE; Ganzevles SH; Fluitsma DM; Schilham MW; Beelen RH; Valerius T; Lohse S; Glennie MJ; Medema JP; van Egmond M
J Immunol; 2011 Jul; 187(2):726-32. PubMed ID: 21653835
[TBL] [Abstract][Full Text] [Related]
18. Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies.
Heijnen IA; Rijks LJ; Schiel A; Stockmeyer B; van Ojik HH; Dechant M; Valerius T; Keler T; Tutt AL; Glennie MJ; van Royen EA; Capel PJ; van de Winkel JG
J Immunol; 1997 Dec; 159(11):5629-39. PubMed ID: 9548506
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.
Guyre PM; Graziano RF; Vance BA; Morganelli PM; Fanger MW
J Immunol; 1989 Sep; 143(5):1650-5. PubMed ID: 2474608
[TBL] [Abstract][Full Text] [Related]
20. Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells.
Sundarapandiyan K; Keler T; Behnke D; Engert A; Barth S; Matthey B; Deo YM; Graziano RF
J Immunol Methods; 2001 Feb; 248(1-2):113-23. PubMed ID: 11223073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
